We are pleased to announce that Regensight will be the Main Sponsor of the World Congress on Keratoconus 2025, which will be held in Athens, Greece, from June 12 to 14.
This prestigious event brings together the world’s leading experts to discuss the latest innovations in the diagnosis and treatment of keratoconus. Regensight will be the protagonist with its proprietary theranostics technology that is redefining the future of corneal cross-linking treatment with a precise, personalized and predictive approach.
For more information: wkcongress2025.com.